Cargando…
Neuroimage Biomarker Identification of the Conversion of Mild Cognitive Impairment to Alzheimer’s Disease
An efficient method to identify whether mild cognitive impairment (MCI) has progressed to Alzheimer’s disease (AD) will be beneficial to patient care. Previous studies have shown that magnetic resonance imaging (MRI) has enabled the assessment of AD progression based on imaging findings. The present...
Autores principales: | Kung, Te-Han, Chao, Tzu-Cheng, Xie, Yi-Ru, Pai, Ming-Chyi, Kuo, Yu-Min, Lee, Gwo Giun Chris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968420/ https://www.ncbi.nlm.nih.gov/pubmed/33746695 http://dx.doi.org/10.3389/fnins.2021.584641 |
Ejemplares similares
-
Multimodal MRI Neuroimaging Biomarkers for Cognitive Normal Adults, Amnestic Mild Cognitive Impairment, and Alzheimer's Disease
por: Lin, Ai-Ling, et al.
Publicado: (2012) -
Nonlinear biomarker interactions in conversion from mild cognitive impairment to Alzheimer's disease
por: Popescu, Sebastian G., et al.
Publicado: (2020) -
Effect of HMGCR genetic variation on neuroimaging biomarkers in healthy, mild cognitive impairment and Alzheimer's disease cohorts
por: Cao, Lei, et al.
Publicado: (2016) -
Increased prediction value of biomarker combinations for the conversion of mild cognitive impairment to Alzheimer’s dementia
por: Zhao, Aonan, et al.
Publicado: (2020) -
Predictive models for mild cognitive impairment to Alzheimer’s disease conversion
por: Skolariki, Konstantina, et al.
Publicado: (2021)